The estimated Net Worth of Michael C. Plansky is at least $763 millier dollars as of 14 June 2022. Mr. Plansky owns over 22,831 units of SIGA Technologies Inc stock worth over $622,061 and over the last 7 years he sold SIGA stock worth over $0. In addition, he makes $141,000 as Independent Director at SIGA Technologies Inc.
Sign up
Mr. Plansky SIGA stock SEC Form 4 insiders trading
Michael has made over 5 trades of the SIGA Technologies Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 22,831 units of SIGA stock worth $171,461 on 14 June 2022.
The largest trade he's ever made was exercising 22,831 units of SIGA Technologies Inc stock on 14 June 2022 worth over $171,461. On average, Michael trades about 11,833 units every 212 days since 2017. As of 14 June 2022 he still owns at least 82,831 units of SIGA Technologies Inc stock.
You can see the complete history of Mr. Plansky stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michael Plansky biography
Michael C. Plansky serves as Independent Director of the Company. Mr. Plansky has served as a director of SIGA since May 2017. Mr. Plansky has 35 years of experience at KPMG LLP where he served in a variety of senior leadership positions until his retirement in 2010. From 2005-2009, he was the National Partner in Charge, Risk Management – Audit, and Regional Risk Management Partner, serving on the firm’s Professional Practice Committee and having responsibility for oversight of risk management for the Americas region. Mr. Plansky also served as the firm’s Ombudsman and a member of its Legal and Compliance Committee and Management Review Panel. Earlier in his tenure, he held the roles of Lead Audit Engagement Partner, SEC Reviewing Partner and National Director of the firm’s Consumer Products Practice, serving a broad range of global public companies. Also, Mr. Plansky served as a director on ANN INC.’s Board of Directors between 2011 and 2015 and was an Adjunct Associate Professor at New York University’s Leonard N. Stern School of Business. Mr. Plansky provides our Board with broad accounting expertise, including significant knowledge in audit and risk management, and extensive experience across many industries.
What is the salary of Michael Plansky?
As the Independent Director of SIGA Technologies Inc, the total compensation of Michael Plansky at SIGA Technologies Inc is $141,000. There are 10 executives at SIGA Technologies Inc getting paid more, with Daniel Luckshire having the highest compensation of $1,684,000.
How old is Michael Plansky?
Michael Plansky is 70, he's been the Independent Director of SIGA Technologies Inc since 2017. There are 1 older and 12 younger executives at SIGA Technologies Inc. The oldest executive at SIGA Technologies Inc is Thomas Constance, 83, who is the Independent Director.
What's Michael Plansky's mailing address?
Michael's mailing address filed with the SEC is C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK, NY, 10065.
Insiders trading at SIGA Technologies Inc
Over the last 21 years, insiders at SIGA Technologies Inc have traded over $65,185,125 worth of SIGA Technologies Inc stock and bought 6,065,626 units worth $33,817,674 . The most active insiders traders include Holdings Incperelman Ronald..., Pharma Inc Transtech et Adnan M M Mjalli. On average, SIGA Technologies Inc executives and independent directors trade stock every 36 days with the average trade being worth of $1,122,865. The most recent stock trade was executed by Dennis E Hruby on 1 July 2024, trading 32,258 units of SIGA stock currently worth $242,258.
What does SIGA Technologies Inc do?
at siga, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, ebola, dengue, lassa fever and other dangerous viruses. our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.
What does SIGA Technologies Inc's logo look like?
Complete history of Mr. Plansky stock trades at SIGA Technologies Inc
SIGA Technologies Inc executives and stock owners
SIGA Technologies Inc executives and other stock owners filed with the SEC include:
-
Daniel Luckshire,
Chief Financial Officer, Executive Vice President, Secretary -
Dr. Phillip Louis Gomez III, M.D., Ph.D.,
CEO & Director -
Phillip Gomez,
Chief Executive Officer, Director -
Robin Abrams,
Chief Administrative Officer, General Counsel -
Dr. Dennis E. Hruby,
Exec. VP & Chief Scientific Officer -
Dennis Hruby,
Chief Scientific Officer, Vice President -
Daniel J. Luckshire,
Exec. VP, CFO & Sec. -
Robin E. Abrams,
Gen. Counsel & Chief Admin. Officer -
Eric Rose,
Chairman of the Board -
Julie Kane,
Independent Director -
Michael Plansky,
Independent Director -
Joseph Marshall,
Independent Director -
James Antal,
Independent Director -
Thomas Constance,
Independent Director -
Herb Vloedman,
Chief Information Officer -
Tove C. Bolken,
Sr. VP of Operations & Chief Supply Chain Officer -
Diem Nguyen,
Chief Executive Officer -
Larry R. Miller,
General Counsel -
Holdings Incperelman Ronald...,
-
Bruce Slovin,
Director -
Paul G Savas,
-
Jeffrey B Kindler,
-
Scott M Hammer,
Director -
Donald G Drapkin,
Director -
Bernard L Kasten,
Chief Executive Officer -
Ayelet Dugary,
Acting Chief Financial Officer -
Judy S Slotkin,
Director -
Michael Md Weiner,
Director -
Thomas N Konatich,
CFO, Secretary and Treasurer -
Adnan M M Mjalli,
Director -
John Odden,
VP - Business Development -
Ronald O Mac Andrews & Forb...,
-
William C Bevins,
Director -
Susan K Burgess,
President -
Michael J Bayer,
Director -
Frances F Townsend,
Director -
William J Ii Haynes,
Executive VP & General Counsel -
Steven L Fasman,
Director -
Pharma Inc Transtech,
10% owner -
& Forbes Holdings Inc.Perel...,
-
Mehmet C Md Oz,
Director -
Donald G Drapkin,
Director -
Evan A. Knisely,
-
Edward P. Taibi,
-
Holly L. Phillips,
-
Jaymie A Durnan,
-
Gary J. Nabel,
-
Julian Nemirovsky,
-
Harold Eugene Jr. Ford,
-
Jay Varma,
EVP & Chief Medical Officer